Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Avacta Group (AVCT) Share News

Avacta To Submit Application For TMAC Linker Testing In Tumours Study

3rd Jun 2019 10:20

LONDON (Alliance News) - Avacta Group PLC on Monday said it is planning to submit an application to test its TMAC linker in patients with selected solid tumours in early 2020.The company, a Read More

Avacta Shares Fall On Widened Interim Loss, Lower Revenue

9th Apr 2019 09:49

LONDON (Alliance News) - Avacta Group PLC on Tuesday reported a widened first half loss mainly due to lower income contribution from life sciences unit.The stock was trading 8.5% lower on a Read More

Avacta Hires IP Group Unit Boss Sam Williams As Non-Executive Director

28th Jan 2019 12:01

LONDON (Alliance News) - Avacta Group PLC on Monday said it has appointed Sam Williams as a non-executive director with immediate effect.The biotechnology company said Williams is currently Read More

IP Group Builds Over 17% Holding In Biotechnology Firm Avacta (ALLISS)

3rd Jan 2019 11:34

LONDON (Alliance News) - Avacta Group PLC on Thursday said IP Group PLC now holds 17.2% stake in the biotechnology company following a transaction on December 18.Prior to that, IP holding Read More

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer

12th Dec 2018 11:14

LONDON (Alliance News) - Reagents developer Avacta Group PLC on Wednesday appointed Jose Saro as chief medical officer to lead the firm's therapeutic development strategy.Saro brings 20 Read More

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate

10th Dec 2018 08:52

LONDON (Alliance News) - IP Group PLC on Monday said its portfolio company Avacta Group PLC signed a development & license deal with LG Chem Life Sciences.IP Group currently holds a in Read More

Avacta Annual Revenue Increases But Loss Widens On Higher Expenses

2nd Oct 2018 09:42

LONDON (Alliance News) - Avacta Group PLC on Tuesday said its loss widened in its recently-ended financial year on higher costs, as it continues to progress Affimer.The reagents developer a Read More

FIL Reduces Avacta Stake To Below 5% Threshold After Deal (ALLISS)

23rd Aug 2018 17:38

LONDON (Alliance News) - Avacta Group PLC said Thursday that FIL Ltd decreased its stake in the biotechnology company to below 5% after a transaction on Tuesday.FIL lowered its holding to a Read More

Lombard Odier Asset Management Lowers Holding In Avacta (ALLISS)

23rd Aug 2018 14:20

LONDON (Alliance News) - Avacta Group PLC on Thursday said Lombard Odier Asset Management Europe Ltd reduced its holding in the biotechnology company.In a transaction on Tuesday, Lombard to Read More

UPDATE: Avacta Raises GBP12 Million To Fund New Drug Development (ALLISS)

30th Jul 2018 18:17

LONDON (Alliance News) - Biotherapeutics firm Avacta Group PLC late Monday said it raised GBP11.6 million before expenses to help fund new drug development partnerships.Early on Monday, to Read More

Avacta Sets GBP11.4 Million Share Offer To Fund New Drug Development (ALLISS)

30th Jul 2018 12:48

LONDON (Alliance News) - Biotherapeutics firm Avacta Group PLC on Monday said it plans to raise GBP11.4 million in a share placing and subscription to help fund new drug development is to place at Read More

Avacta Appoints Ex-Immunocore Boss Eliot Forster As Chairman

11th Jun 2018 10:48

LONDON (Alliance News) - Biotechnology firm Avacta Group PLC said Monday it appointed ex-Immunocore Ltd boss Eliot Forster as its non-executive chairman.Forster served as Immunocore CEO in Read More

Avacta Says Non-Executive Director Michael Albin To Stand Down Friday

29th Mar 2018 13:58

LONDON (Alliance News) - Avacta Group PLC, a healthcare products company that specialises in Affimer products that bind molecules together, said Thursday that non-executive be Read More

DIRECTOR DEALINGS: Avacta Chief Executive Officer Smith Buys Shares

13th Mar 2018 14:26

LONDON (Alliance News) - Avacta Group PLC said its Chief Executive Officer Alastair Smith bought shares in the biotechnology company in transaction on Tuesday.Smith at Read More

Avacta Adds Cancer Stem Cell Specialist Evan To Scientific Board

7th Nov 2016 09:41

Avacta Reports Good First Results From Affimer Pre-Clinical Trials

22nd Sep 2016 07:57

Avacta-Leeds University Partnership Gets GBP3.8 Million Grant

10th Aug 2016 07:43

Avacta Collaborating With Glythera To Develop Antibody Drugs

14th Jul 2016 08:34

Avacta Identifies Affimer Proteins For Possible Zika Virus Tests

22nd Jun 2016 06:37

Avacta Forms Partnership With Mologic To Develop Point-Of-Care Tests

13th Jun 2016 08:23

FTSE 100 Latest

Value8,774.65

Change-17.15